ACS Macro Letters
ACS Macro Letters
5 years ago

Polypeptide-Grafted Nanodiamonds for Controlled Release of Melittin to Treat Breast Cancer

Polypeptide-Grafted Nanodiamonds for Controlled Release of Melittin to Treat Breast Cancer
Pu Xiao, Haiwang Lai, Mingxia Lu, Martina H. Stenzel, Fan Chen
A peptide vector consisting of nanodiamonds (NDs) and PEGylated polyglutamic acid (ND@PLGPEG-co-PLGA) has been designed and developed. The negative charges at the surface of the vector were exploited to bind a positively charged peptide drug melittin via electrostatic interaction. The surface was saturated when the weight ratio of ND@PLGPEG-co-PLGA to melittin (MEL) was 5 to 1. The desorption of melittin from the surface was controlled by pH, with almost no melittin released from the nanoparticles under physiological pH conditions in 2 days. However, steady release was detected in an acidic environment. The preserved structure and activity of bound melittin were demonstrated by the HPLC and 2D MCF-7 cell culture models, respectively. The bound melittin exhibited improved toxicity toward MCF-7 cells dependent on the concentration of MEL in NDs. Our results suggested that the negatively charged polymer-coated NDs were able to release the cargo upon exposure to breast cancer cells.

Publisher URL: http://dx.doi.org/10.1021/acsmacrolett.7b00389

DOI: 10.1021/acsmacrolett.7b00389

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.